Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/1/2026

Management of Diffuse Axonal Injury

Diagnostic Approach

  • Non-contrast CT (NCCT) is the first-line imaging modality in acute moderate to severe TBI and can predict mortality and unfavorable outcomes (class I recommendation) 1, 2
  • NCCT has limitations in detecting DAI, as microhemorrhages associated with axonal injury may not be visible on conventional CT 1, 3
  • MRI is indicated when NCCT results are normal but persistent unexplained neurologic findings are present (class I recommendation) 1, 4
  • Specific MRI sequences for optimal DAI detection include T2*-weighted gradient-echo (GRE) imaging, sensitive to microhemorrhages in acute, early subacute, and chronic stages of DAI (evidence level II) 1, 5
  • Susceptibility-weighted imaging (SWI) is 3-6 times more sensitive than T2* GRE in detecting hemorrhagic axonal injuries (evidence level II) 6, 7
  • Diffusion-weighted imaging (DWI) allows visualization of axonal injuries not easily appreciated on other sequences 5, 8

Prognostic Assessment

  • The location and extent of DAI lesions correlate with clinical outcomes, with DAI Stage 3 (dorsolateral brain stem lesions) associated with poor outcomes 7
  • The presence of both a contusion and >4 foci of hemorrhagic axonal injury on MRI is an independent prognostic predictor 1, 2
  • Early subacute MRI findings (small cortical contusions or hemorrhagic axonal injury) improve prediction of 3-month outcomes 7

Management Strategies

  • Management focuses on preventing secondary brain injury as there is no specific treatment for the primary axonal damage 9
  • Gadolinium-based contrast agents are not necessary for conventional MRI in TBI (class IIb recommendation) 1, 4
  • Diffusion Tensor Imaging (DTI) shows promise in research settings but has insufficient evidence to support routine clinical use at the individual patient level 7, 10
  • Regular multidisciplinary case reviews are recommended for patients with severe DAI 9
  • Consider advanced communication training for healthcare providers managing patients with limited prospect of recovery 9

Common Pitfalls and Caveats

  • The number of microhemorrhages, while helpful for accurate diagnosis of DAI, is not currently thought to be associated with injury severity or outcomes (evidence level II) 1, 2

Timing of DAI Visibility on MRI After Head Injury

Acute Phase Detection (0-7 Days)

  • The American College of Radiology recommends that MRI can detect DAI lesions within the first 24 hours after traumatic brain injury, with optimal sensitivity using multiple specialized sequences 11, 12, 13
  • The combination of T2-weighted, T2*-weighted, and diffusion-weighted sequences provides the highest detection rate for DAI, as more than 80% of DAI lesions lack macroscopic hemorrhage visible on CT 11, 12, 13
  • Most MRI studies in acute TBI are performed within 5 days of injury, with a median timing of 1 day (range 0-35 days) in research cohorts 14

Optimal Timing for Prognostic Assessment

  • A prospective multicenter study found that approximately 27% of mild TBI patients with normal CT showed abnormalities on early MRI (small cortical contusions or hemorrhagic axonal injury) that improved prediction of 3-month outcomes 12, 13

Common Pitfalls

  • Only 10% of DAI is positive on CT because most lesions lack macroscopic hemorrhage, making MRI essential for comprehensive evaluation 11, 12, 13

Evidence‑Based Guidelines for Diffuse Axonal Injury (DAI)

Prognosis

  • Extensive brainstem lesions in Grade III DAI are associated with a 75 % mortality rate. 15

Imaging Assessment

  • Non‑contrast computed tomography should be obtained immediately as the first‑line study, but clinicians must recognize its limited sensitivity for detecting DAI. 16

Neurological Monitoring

  • The motor component of the Glasgow Coma Scale (GCS) should be recorded every 15–30 minutes during the initial resuscitation period and then hourly thereafter to track neurologic status. 17

Grade‑Specific Management

Grade I DAI

  • Patients should be admitted to a monitored bed with hourly neurologic examinations for the first 12 hours. 17
  • Routine repeat CT scanning is not recommended unless there is a clinical deterioration defined as a ≥2‑point drop in GCS; this approach avoids unnecessary imaging. 18

Grade II DAI

  • Admission to a neurosurgical intensive‑care unit is advised for continuous monitoring of neurologic and physiologic parameters. 15

Grade III DAI

  • An urgent neurosurgical consultation is warranted to evaluate the need for intracranial pressure (ICP) monitoring device placement. 15

Impact of Repeat CT Imaging

  • In patients with mild‑to‑moderate traumatic brain injury who do not exhibit clinical worsening, repeat CT scans lead to a change in management in only about 2.3 % of cases. 18

REFERENCES

7

acr appropriateness criteria® head trauma: 2021 update. [LINK]

Journal of the American College of Radiology, 2021

10

acr appropriateness criteria® head trauma: 2021 update. [LINK]

Journal of the American College of Radiology, 2021

11

acr appropriateness criteria® head trauma: 2021 update. [LINK]

Journal of the American College of Radiology, 2021

12

acr appropriateness criteria® head trauma: 2021 update. [LINK]

Journal of the American College of Radiology, 2021

13

acr appropriateness criteria® head trauma: 2021 update. [LINK]

Journal of the American College of Radiology, 2021